Cargando…
Genetic Variant as a Selection Marker for Anti–Prostate Stem Cell Antigen Immunotherapy of Bladder Cancer
A monoclonal antibody against prostate stem cell antigen (PSCA) has emerged as a novel cancer therapy currently being tested in clinical trials for prostate and pancreatic cancers, but this treatment is likely to be efficient only in patients with PSCA-expressing tumors. The present study demonstrat...
Autores principales: | Kohaar, Indu, Porter-Gill, Patricia, Lenz, Petra, Fu, Yi-Ping, Mumy, Adam, Tang, Wei, Apolo, Andrea B., Rothman, Nathaniel, Baris, Dalsu, Schned, Alan R., Ylaya, Kris, Schwenn, Molly, Johnson, Alison, Jones, Michael, Kida, Masatoshi, Silverman, Debra T., Hewitt, Stephen M., Moore, Lee E., Prokunina-Olsson, Ludmila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3536639/ https://www.ncbi.nlm.nih.gov/pubmed/23266392 http://dx.doi.org/10.1093/jnci/djs458 |
Ejemplares similares
-
A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk
por: Fu, Yi-Ping, et al.
Publicado: (2011) -
Prostate stem cell antigen (PSCA) and risk of bladder cancer: linking genotypes to functional mechanisms
por: Mumy, Adam, et al.
Publicado: (2011) -
Functional exploration of CCNE1 splicing forms as a possible link to bladder cancer susceptibility
por: Kohaar, Indu, et al.
Publicado: (2011) -
Disinfection By-Products in Drinking Water and Bladder Cancer: Evaluation of Risk Modification by Common Genetic Polymorphisms in Two Case–Control Studies
por: Beane Freeman, Laura E., et al.
Publicado: (2022) -
An unusual suspect: an uncommon human-specific synonymous coding variant within the UGT1A6 gene explains a GWAS signal and protects against bladder cancer
por: Tang, Wei, et al.
Publicado: (2011)